UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Newton One Investments LLC

Newton One Investments LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 9.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 611 shares of the healthcare conglomerate’s stock after selling 63 shares during the period. Newton One Investments LLC’s holdings in UnitedHealth Group were worth $309,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. Commonwealth Financial Services LLC boosted its stake in UnitedHealth Group by 26.3% during the 4th quarter. Commonwealth Financial Services LLC now owns 1,004 shares of the healthcare conglomerate’s stock worth $508,000 after purchasing an additional 209 shares during the period. Rockline Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 1.6% during the fourth quarter. Rockline Wealth Management LLC now owns 12,305 shares of the healthcare conglomerate’s stock worth $6,225,000 after buying an additional 192 shares during the period. Cullinan Associates Inc. increased its position in UnitedHealth Group by 5.4% in the 4th quarter. Cullinan Associates Inc. now owns 18,498 shares of the healthcare conglomerate’s stock valued at $9,357,000 after acquiring an additional 950 shares during the period. Tempus Wealth Planning LLC lifted its holdings in shares of UnitedHealth Group by 16.4% during the fourth quarter. Tempus Wealth Planning LLC now owns 1,003 shares of the healthcare conglomerate’s stock worth $507,000 after purchasing an additional 141 shares during the period. Finally, Flavin Financial Services Inc. purchased a new position in UnitedHealth Group during the fourth quarter worth about $2,274,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $548.65 on Tuesday. The company has a market cap of $504.91 billion, a P/E ratio of 35.40, a PEG ratio of 1.48 and a beta of 0.61. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business has a 50 day moving average of $536.17 and a two-hundred day moving average of $565.20.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 EPS. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on UNH shares. Royal Bank of Canada reduced their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Barclays decreased their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. TD Cowen boosted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.